Head and Neck Mucosal Melanoma in the Era of Immunotherapy: A National Cancer Database Review
Head & Neck · 2026-09 · 48 (9) · 2491-2498
DOI: 10.1002/hed.70270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, online erschienen am 08.04.2026. Verfasst von Lilah Kahloon und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Louisville, Louisville, Kentucky, USA. Hauptthemen laut MEDLINE: Melanoma, Head and Neck Neoplasms, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Head and neck mucosal melanoma (HNMM) is a rare, aggressive malignancy with poor survival and no standardized treatment. This study investigates the role and sequencing of surgery, radiation, immunotherapy, and chemotherapy in HNMM management.
Methods
The National Cancer Database was queried for HNMM cases from 2004 to 2020. Parameters included patient demographics, disease characteristics, treatment types, and survival outcomes. Multivariable Cox proportional hazards models were used to demonstrate associations between disease characteristics and treatment type and sequence on overall survival.
Results
A total of 3704 adult cases were included. Advanced age, positive surgical margins, advanced stage, male sex, and treatment outside of an academic center were correlated with reduced survival. Surgery was utilized in most cases (79.3%) and its inclusion in any treatment combination significantly improved survival (HR = 0.52, p < 0.001). Immunotherapy following surgery showed improved survival (HR = 0.87, p = 0.017). The use of radiation or chemotherapy alone correlated with poorer survival. Multimodal treatments showed survival benefits, particularly those that included both surgery and immunotherapy.
Conclusions
Surgery remains paramount in the treatment of HNMM. Immunotherapy shows promise in multimodal regimens, though optimal sequencing warrants further investigation. Standardized guidelines and prospective studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of Louisville, Louisville, Kentucky, USA.
- Department of Radiation Oncology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
- Department of Otolaryngology-Head & Neck Surgery & Communicative Disorders, University of Louisville School of Medicine, Louisville, Kentucky, USA.
- UofL Health-Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA.
- Department of Bioinformatics and Biostatistics, UofL Health-Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA.
ORCID-Profile: Lilah Kahloon, Tanya Gupta
Zitieren
APA
Kahloon, L., Ishteiwy, R., Gupta, T., Albert, C., Crawford, D., Liu, Z., Kong, M., Dunlap, N., Cash, E., & Townsend, M. (2026). Head and Neck Mucosal Melanoma in the Era of Immunotherapy: A National Cancer Database Review. Head & Neck, 48(9), 2491-2498. https://doi.org/10.1002/hed.70270
Vancouver
Kahloon L, Ishteiwy R, Gupta T, Albert C, Crawford D, Liu Z, et al. Head and Neck Mucosal Melanoma in the Era of Immunotherapy: A National Cancer Database Review. Head & Neck. 2026;48(9):2491-2498. doi:10.1002/hed.70270
BibTeX
@article{Kahloon2026,
author = {Kahloon, Lilah and Ishteiwy, Reema and Gupta, Tanya and Albert, Christina and Crawford, Devaughn and Liu, Zhanxu and Kong, Maiying and Dunlap, Neal and Cash, Elizabeth and Townsend, Melanie},
title = {Head and Neck Mucosal Melanoma in the Era of Immunotherapy: A National Cancer Database Review},
journal = {Head & Neck},
year = {2026},
volume = {48},
number = {9},
pages = {2491--2498},
doi = {10.1002/hed.70270}
}
EUVIMED